Effect of angiotensin-converting enzyme therapy on QT interval dispersion

American Journal of Therapeutics

Volumn 6, Issue 5, 1999, Pages 257-261

  Ranade, Vasant ^b   Molnar, Janos ^b   Khokher, Tahir ^b   Agarwal, Anupam ^b   Mosnaim, Aron ^b   Somberg, John C ^a  

^a American Institute of Therapeutics   (United States)

^b NONE

Author keywords

ACE inhibition; CHF; QT dispersion

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

ARTICLE; CONTROLLED STUDY; HEART EJECTION FRACTION; HEART FAILURE; HEART RATE; HEART REPOLARIZATION; HEART SIZE; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; QT INTERVAL; SUDDEN DEATH;

EID: 0032877233     PISSN: 10752765     EISSN: None     Source Type: Journal    
DOI: 10.1097/00045391-199909000-00005     Document Type: Article

References (26)

1. CONSENSUS trial study group: Effect of enalapril on mortality in severe congestive heart failure. N Engl J Med 1987;316:1429-1434.
2. SOLVD investigators: Effect of enalapril on survival in patients with reduced left ventricular ejection fraction and congestive heart failure. N Engl J Med 1991;325:293-302.
3. Cowan JC, Yusoff K, Moore M, et al: Importance of lead selection in QT interval measurement. Am J Cardiol 1988;61:83-87.
4. Day CP, McComb JM, Campbell RWF: QT dispersion: an indication of arrhythmia risk in patients with long QT intervals. Br Heart J 1990;63:342-441.
5. Priori SG, Napolitano C, Diehl L, Schwartz P: Dispersion of the QT interval: a marker of therapeutic efficacy in idiopathic long QT syndrome. Circulation 1994;89:1681-1689.
6. Jackman WM, Friday KJ, Anderson JL, Aliot EM, Clark M, Lazzara R: The long QT syndromes: a critical review, new clinical observations and a unifying hypothesis. Prog Cardiovasc Dis 1988;31:115-172.
7. Barr CS: AT dispersion and sudden unexpected death in chronic heart failure. Lancet 1994;343:327-329.
8. Schwartz PJ, Wolf S: QT interval prolongation as predictor of sudden death in patients with myocardial infarction. Circulation 1978;57:1074-1077.
9. Grimm W, Steder U, Menz V, et al: QT dispersion and arrhythmic events in idiopathic dilated cardiomyopathy. Am J Cardiol 1996;78:458-461.
10. Buja G, Miorelli M, Turrini P, et al: Comparison of QT dispersion in hypertrophic cardiomyopathy between patients with and without ventricular arrhythmias and sudden death. Am J Cardiol 1993;72:973-974.
11. Bauman JL, Bauernfeind RA, Hoff JV, et al: Torsade de pointes due to quinidine: observations in 31 patients. Am Heart J 1984;107:425.
12. Pratt CM, Ruberg S, Mortanroth J, et al: Dose-response relation between terfenadine (Seldane) and the QTc interval on the scalar electrocardiogram: distinguishing a drug effect from spontaneous variability. Am Heart J 1996;131:472-480.
13. Cushman DW, Cheung HS: Spectrophotometric assay and properties of the angiotensin converting enzyme of rabbit lung. Biochem Pharmacol 1971;20:1637-1648.
14. Cushman DW, Cheung HS: Concentrations of angiotensin-converting enzyme in tissues of the rat. Biochem Biophys Acta 1971;250:261-265.
15. Galium RF: Heart failure in the United States 1970-1985. Am Heart J 1986;113:1043-1045.
16. Packer M: Prolonging life in patients with congestive heart failure: the next frontier. Circulation 1987;75(suppl IV):IV-1-3.
17. Australia/New Zealand Heart Failure Research Collaborative Group: Randomised, placebo-controlled trial of carvedilol in patients with congestive heart failure due to ischaemic heart disease. Lancet 1997;349:375-380.
18. Packer M, Bristow MR, Cohn JN: The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. N Engl J Med 1996;334:1349-1355.
19. The Captopril-Digoxin Multicenter Research Group: Comparative effects of therapy with captopril and digoxin in patients with mild to moderate heart failure. JAMA 1988;259:539-544.
20. Cohn JN, Johnson G, Ziesche S, et al: A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure. N Engl J Med 1991;325:303.
21. Hu JT, Wyse DG, Gillis AM, et al: Precordial QT interval dispersion as a marker of torsade de pointes. Circulation 1992;86:1376-1382.
22. Napolitano C, Priori SG, Schwartz PJ: Torsade de pointes mechanisms and management. Drugs 1994;47: 51-65.
23. Loo AVD, Arendts W, Hohnloger S: Variability of QT dispersion measurements in the surface electrocardiogram in patients with acute myocardial infarction and in normal subjects. Am J Cardiol 1994;74:1113-1118.
24. Lee KW, Okin PM, Kligfield P, Stein KM, Lerman BB: Precorclial QT dispersion and inducible ventricular tachycardia. Am Heart J 1997;134:1005-1013.
25. Stajer D, Mozina H, Noc M, Rode P: Correlation between Qtc interval duration and left ventricular systolic dysfunction in patients with acute myocardial infarction. J Electrocardiol 1993;26:333-339.
26. Pfeffer MA, Braunwald IU, Moye LA, et al: Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. N Engl J Med 1992;327:669.